Seres Therapeutics (MCRB) Price to Earnings (2015 - 2026)
Seres Therapeutics' (MCRB) quarterly Price to Earnings came in at 3.68 in Q2 2026, up 8.02% year-over-year from 3.4 in Q2 2025, and up 11.07% quarter-over-quarter from 4.13 in Q1 2026.
Powered by 
Analysis
Seres Therapeutics (MCRB) Price to Earnings (2015 - 2026) Analysis & Trends
Seres Therapeutics has disclosed Price to Earnings across 12 years of filings, most recently posting 3.68 for Q2 2026.
- In Q2 2026, Price to Earnings rose 8.02% year-over-year to 3.68; the TTM figure through Jun 2026 stood at 0.94 (down 130.88% YoY), while the FY2025 annual figure was 1.55, down 109.23% from the prior year.
- Price to Earnings came in at 3.68 for Q2 2026 at Seres Therapeutics, up from 4.13 in the prior quarter.
- In the past five years, Price to Earnings ranged from a high of 13.17 in Q2 2023 to a low of 319.18 in Q4 2022.
- Average Price to Earnings over 5 years is 22.12, with a median of 4.75 recorded in 2022.
- Year-over-year, Price to Earnings sank 1971.83% in 2022 and surged 368.1% in 2023.
- Over 5 years, Price to Earnings stood at 319.18 in 2022, then soared by 98.58% to 4.55 in 2023, then dropped by 11.36% to 5.06 in 2024, then plunged by 48.36% to 7.51 in 2025, then surged by 51.06% to 3.68 in 2026.
- Per Business Quant data, the three most recent Price to Earnings figures were 3.68 in Q2 2026, 4.13 in Q1 2026, and 7.51 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Seres Therapeutics | 49.89 Mn | 49.89 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.68 |
| Mar 31, 2026 | -4.13 |
| Dec 31, 2025 | -7.51 |
| Sep 30, 2025 | -7.71 |
| Jun 30, 2025 | -4.00 |
| Mar 31, 2025 | -4.59 |
| Dec 31, 2024 | -5.06 |
| Sep 30, 2024 | 1.45 |
| Jun 30, 2024 | -3.34 |
| Mar 31, 2024 | -2.88 |
| Dec 31, 2023 | -4.55 |
| Sep 30, 2023 | -6.27 |
| Jun 30, 2023 | 13.17 |
| Mar 31, 2023 | -10.04 |
| Dec 31, 2022 | -319.18 |
| Sep 30, 2022 | -13.32 |
| Jun 30, 2022 | -4.91 |
| Mar 31, 2022 | -11.67 |
| Dec 31, 2021 | -15.41 |
| Sep 30, 2021 | 9.37 |